DEA's Own Pharmacologist Undercuts Marijuana Rescheduling Order

MMJ International Holdings’ CEO Duane Boise said a government scientific expert testified that marijuana failed the DEA’s traditional medical use standard and lacked reproducible chemistry. The testimony also alleged HHS omitted critical public health findings. The claims increase regulatory risk for medical-use cannabis and are likely a negative near-term catalyst for the affected companies, but without quantified financial impact in the report.

Analysis

MMJ International Holdings’ CEO Duane Boise said a government scientific expert testified that marijuana failed the DEA’s traditional medical use standard and lacked reproducible chemistry. The testimony also alleged HHS omitted critical public health findings. The claims increase regulatory risk for medical-use cannabis and are likely a negative near-term catalyst for the affected companies, but without quantified financial impact in the report.